Unlike platelet growth factors which will work directly on tendon or ligament cells, BPC-157 doesnt work that way, as it has no effect for example on tendon cells in culture, but does help tendon cells in animals (3)
Patients should follow the personalized regimen given by the provider
BPC-157 (Body Protective Compound-157) , 17 ,
(3) BPC 157 may have a particular additional effect during the injury on the blood vessel activity: vessel recruitment to circumvent the vessel occlusion The final argumentation goes to the findings that BPC 157 may have a particular additional effect during the injury on the blood vessel activity, much like vessel recruitment to circumvent the vessel occlusion, presenting an additional shunting and rapid bypassing loops to rapidly reestablish blood flow integrity
This regulatory status reflects the absence of completed human clinical trials establishing safety and efficacy to approval standards
10.1053/j.gastro.2016.03.035 19